GrowthCurve Capital Takes Majority Stake in Patient Affordability Platform TailorMed
GrowthCurve Capital, a New York-based private equity firm, has acquired a majority stake in TailorMed, a company that sells a platform to help patients afford medical care and medications.2
By Victoria Shi · AI Funding Reporter Nov 9, 2026

The deal was announced on November 2, 2026, according to Morningstar. While financial terms were not officially disclosed, reports from Israeli publications Calcalist and Globes valued the deal at around $250 million, according to dealroom.co and other media reports.3
TailorMed said in a LinkedIn post that it would partner with GrowthCurve for its "next phase of growth." The investment is intended to speed up the development of TailorMed's platform and expand its artificial intelligence tools for providers, pharmacies, and patients, peprofessional.com reported.1,2
Founded in 2018, TailorMed offers a platform that helps providers and pharmacies proactively identify, match, and enroll patients in financial assistance programs, according to Clinical Terminal data. The company states its network includes more than 950 hospitals, 4,700 clinics, and 3,100 pharmacies, and that it has secured over $7.4 billion in financial aid for patients since 2020, Morningstar reported. Clinical Terminal lists Advocate Health, Moffitt Cancer Center, and Stony Brook Medicine among TailorMed's customers.3,6
"When we founded TailorMed, we set out to solve a deeply personal problem for millions of Americans who had acute health conditions but were unable to access the medications they had been prescribed," Srulik Dvorsky, CEO and Co-Founder of TailorMed, said in a statement reported by Morningstar.3
The investment represents an exit for most of TailorMed's previous investors, according to startupresearcher.com. The company had previously raised about $60 million from backers including Sanara Ventures, TriVentures, Accelmed, and Samsung Next. TailorMed's current management team will continue to lead the company, and its approximately 120 employees are expected to remain in their roles. With the new backing, TailorMed may also seek to acquire other companies, Globes reported.4,5